The SARS-CoV-2/Influenza A+B/RSV/Adenovirus Antigen Combo Rapid Test (Nasopharyngeal Swab) is a rapid chromatographic immunoassay for the qualitative detection of SARS-CoV-2 Nucleocapsid protein, Influenza A, Influenza B, Respiratory Syncytial Virus(RSV) and Adenovirus antigens present in human nasopharynx.
Product Features
Fast results
Easy visual interpretation
Simple operation, no equipment required
High accuracy
PRODUCT SPECIFICATION
- PrincipleChromatographic Immunoassay
- FormatCassette
- SpecimenSwab
- CertificateCE
- Reading Time15 minutes
- Pack20 T
-
Storage Temperature
2-30°C
- Shelf Life2 Years
- Sensitivity96.4%(SARS-CoV-2) / 95%(Influenza A) / 92.9%(Influenza B) / 94.3%(RSV) / 96.9%(Adenovirus)
- Specificity99.0%(SARS-CoV-2) / 99.1%(Influenza A) / 99.1%(Influenza B) / 96.2%(RSV) / 98.6%(Adenovirus)
- Accuracy98.2%(SARS-CoV-2) / 98.4%(Influenza A) / 98.1%(Influenza B) / 95.9%(RSV) / 98.4%(Adenovirus)
Ordering Information
- Cat. No.IRT-545
- ProductSARS-CoV-2/Influenza A+B/RSV/Adenovirus Antigen Combo Rapid Test
- Specimen Swab
- Pack20 T
- Cut-OffSee Insert
